Dimerix

Dimerix Equity Turnover

The Equity Turnover of Dimerix (DXB.AX) as of Oct 11, 2026 is -0.29. In the previous year, Equity Turnover was 0.09 — a change of -414.38% (lower).

Equity Turnover

-0.29

YoY

-414.38%

Last updated:

Equity Turnover of Dimerix is 2026 -0.29 . Equity Turnover of Dimerix was 2025 0.09 . It decreases by -414.38% lower compared to the previous year.

The Dimerix Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2019
0.34 AUD
Jan 1, 2020
0.30 AUD
Jan 1, 2021
3.02 AUD
Jan 1, 2022
0.45 AUD
Jan 1, 2023
0.01 AUD
Jan 1, 2024
0.03 AUD
Jan 1, 2025
0.09 AUD
Jan 1, 2026
-0.29 AUD
The Dimerix Equity Turnover history
YEAREquity TurnoverYoY
-0.29-414.38%
0.09+192.26%
0.03+420.09%
0.01-98.62%
0.45-85.18%
3.02+902.14%
0.30-12.37%
0.34+179.33%
0.12-41.56%
0.21-22.50%
0.27+217.46%
0.09-99.24%
11.22—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Equity Turnover of Dimerix is -0.29 in 2026.

Equity Turnover of Dimerix changed from 0.09 to -0.29, representing a -414.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Dimerix since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Dimerix with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

Profitability — Dimerix

All Key Metrics — Dimerix